MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    A new test for the measuring hand functions in Parkinson’s disease: Psychometric evaluation of the squares test

    E. Goz, F. Soke, A. Genc, B. Donmez Colakoglu, P. Keskinoglu (Izmir, Turkey)

    Objective: The aim of the study was to determine reliability and validity of the ST in PD. Background: Parkinson's disease (PD) is affected hand functions…
  • 2016 International Congress

    Effect of dopamine and L-3,4 – dihydroxyphenylalanine in treatment of experimental parkinsonism

    M.U. Kulmanova (Tashkent, Uzbekistan)

    Objective: To study effect of dopamine and L-3,4 - dihydroxyphenylalanine in treatment of experimental parkinsonism. Background: Prospects of treatment of Parkinson's disease are also closely…
  • 2016 International Congress

    The role of active rehabilitation measures, for maintaining the quality of life of patients after stroke with movement disorders in the general practice conditions

    G. Sadullaeva (Tashkent, Uzbekistan)

    Objective: Assessment of the impact of active rehabilitation measures on quality of life of patients after stroke with movement disorders in primary health care. Background:…
  • 2016 International Congress

    Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases

    A. Smolanka, V. Smolanka, K. Karpinska, M. Dovhanych, T. Havryliv (Uzhhorod, Ukraine)

    Objective: To evaluate the treatment of movement disorders which presented as a consequence of haemorrhage from midbrain cavernous malformations. Background: Few cases of movement disorders…
  • 2016 International Congress

    Participant feedback in the PREDICT-PD study

    C.W. Osborne, J. Bestwick, G. Giovannoni, A.J. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To explore the underlying motivation behind participation in PREDICT-PD and whether this had an influence on later drop out from the study. Background: The…
  • 2016 International Congress

    Fall status and stepping response: Individuals with PD are differently influenced by side-affected

    B.N. Intzandt, E. Beck, M.P. Pereira, Q.J. Almeida (Waterloo, ON, Canada)

    Objective: To identify differences in compensatory stepping responses (CSR) between Parkinson's disease (PD) fallers and non-fallers in response to external perturbations. Specifically, to investigate if…
  • 2016 International Congress

    Reliability of the sensory organization test to predict falls in individuals with Parkinson’s disease

    T.E. Apoznanski, S. Yao, M.K. Jung, J. DiFrancisco-Donoghue (Old Westbury, NY, USA)

    Objective: To determine the ability of the Sensory Organization Test (SOT) to predict falls in individuals with Parkinson's disease (PD). Background: Individuals with PD are…
  • 2016 International Congress

    A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery

    E.M. Feinstein, S.J. Frucht (New York, NY, USA)

    Objective: To improve our understanding of the pathophysiology and etiology of hemifacial spasm (HFS). Background: HFS is involuntary unilateral contractions of the muscles innervated by…
  • 2016 International Congress

    Parkinsonism due to hypermanganism in the background of cirrhosis and recovery by CaNaEDTA

    B. Elibol, H. Onder, G.Y. Cakmakli, E.S. Topcuoglu (Ankara, Turkey)

    Objective: To present a patient diagnosed with secondary hypermanganism due to cirrhosis whose extrapyramidal findings had recovered significantly after chelation therapy. Background: Manganese is an…
  • 2016 International Congress

    Differences in physicians’ understanding of biologic and biosimilar medicines in the USA and Europe

    A.L. Molinari, H.L. Gewanter, M. Reilly, D. Charles (Washington, DC, USA)

    Objective: To evaluate differences in physicians' understanding of biologic and biosimilar medicines in the USA and Europe. Background: Biologic medicines, such as botulinum toxins and…
  • « Previous Page
  • 1
  • …
  • 1701
  • 1702
  • 1703
  • 1704
  • 1705
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley